Jonathan Biller sold $754K of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 18 2025, disclosed Feb 19 2025, 1 day later.

Value, as filed

$754K

1,657 sh × $455.06

Executed

Feb 18 2025

the trade date, as filed

Disclosed

Feb 19 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JB Jonathan Biller EVP and Chief Legal Officer profile →

Jonathan Biller (EVP and Chief Legal Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $1.8M of VRTX (3,720 sh across 2 lots, as filed), executed Feb 17.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 91 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jonathan Biller in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $460K
945 sh × $486.35
Exec Feb 25
Filed Feb 26 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.8M
3,720 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $493K
988 sh × $499.00
Exec Feb 13
Filed Feb 18 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $886K
1,925 sh × $460.43
Exec Feb 11
Filed Feb 12 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $156K
347 sh × $449.00
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $281K
694 sh × $404.21
Exec Oct 2 2025
Filed Oct 3 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.6M
3,433 sh × $459.87
Exec Feb 11 2025
Filed Feb 12 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $461K
999 sh × $461.66
Exec Oct 2 2024
Filed Oct 3 2024 · 5:30 PM ET